<img alt="" height="1" width="1" />IBS Trial Guidance Focuses on Endpoints and DesignFDA news (subscription)An FDA draft guidance is recommending interim strategies for developing treatments for irritable bowel syndrome (IBS) because patient-reported outcome ...<nobr></nobr> |